In search of novel ligands using a structure-based approach: a case study on the adenosine A2A receptor
Open Access
- 15 September 2016
- journal article
- research article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 30 (10) , 863-874
Abstract
In this work, we present a case study to explore the challenges associated with finding novel molecules for a receptor that has been studied in depth and has a wealth of chemical information available. Specifically, we apply a previously described protocol that incorporates explicit water molecules in the ligand binding site to prospectively screen over 2.5 million drug-like and lead-like compounds from the commercially available eMolecules database in search of novel binders to the adenosine A2A receptor (A2AAR). A total of seventy-one compounds were selected for purchase and biochemical assaying based on high ligand efficiency and high novelty (Tanimoto coefficient ≤0.25 to any A2AAR tested compound). These molecules were then tested for their affinity to the adenosine A2A receptor in a radioligand binding assay. We identified two hits that fulfilled the criterion of ~50 % radioligand displacement at a concentration of 10 μM. Next we selected an additional eight novel molecules that were predicted to make a bidentate interaction with Asn2536.55, a key interacting residue in the binding pocket of the A2AAR. None of these eight molecules were found to be active. Based on these results we discuss the advantages of structure-based methods and the challenges associated with finding chemically novel molecules for well-explored targets.Keywords
Funding Information
- Dutch Research Council (714.011.001)
This publication has 46 references indexed in Scilit:
- Identification of Novel Adenosine A2A Receptor Antagonists by Virtual ScreeningJournal of Medicinal Chemistry, 2012
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug DesignJournal of Medicinal Chemistry, 2012
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- The VSGB 2.0 model: A next generation energy model for high resolution protein structure modelingProteins: Structure, Function, and Bioinformatics, 2011
- Biophysical Mapping of the Adenosine A2A ReceptorJournal of Medicinal Chemistry, 2011
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- Structure-Based Discovery of A2AAdenosine Receptor LigandsJournal of Medicinal Chemistry, 2010
- Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor AntagonistsJournal of Medicinal Chemistry, 2010
- Evaluation of Homology Modeling of G-Protein-Coupled Receptors in Light of the A2AAdenosine Receptor Crystallographic StructureJournal of Medicinal Chemistry, 2009
- GLIDA: GPCR ligand database for chemical genomics drug discovery database and tools updateNucleic Acids Research, 2007